Martin Shkreli Goes Back on Promise to Cut Price of $750 Pill
When Turing CEO Martin Shkreli upped the price of Daraprim to $750, he was popular target of patients, doctors, and drugmakers, bashing him for the nonsensical raise. A few weeks later, maybe from all the media attention, he promised to…
Read more
